Biotrics Bioimplants

Since the foundation of botiss biomaterials in 2009, botiss has become a leading developer, manufacturer and marketer of biomaterials for oral tissue regeneration. The botiss Regeneration System products have proven safety, efficacy and reliability in a variety of preclinical and clinical studies and daily clinical work with hundreds of thousands of patients worldwide. As a future-oriented company, botiss biomaterials invests substantially in cutting-edge research such as stem cells and growth factors. We develop new, innovative and patient-tailored materials and aim to optimize established indication-oriented products. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work with hundreds of thousands of patients treated worldwide. According to MDD 93/42/EEC botiss is a legal manufacturer of medical devices. With innovative products, we are continuously developing our holistic 360° system together with international experts. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work, with hundreds of thousands of patients treated worldwide.